Listen to this article on the DDW Podcast: Karen Ooms, Executive Vice President and Head of Statistics with Quanticate, argues that analysing data from real-life patients has finally come of age. Statistical consultants have, for a long time, tried to convey to the pharmaceutical industry the merit of using real world data (RWD) to help create more efficient trial designs […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!